During analysis of NOD1 expression in tumour and normal tissues from patients with CRC, we, and others, found that a single reference gene was not sufficiently accurate to quantify target genes (Kasprzak et al., 2018, 2013). The gene discussed is NOD1; the disease is neoplasm.